Request Appointment
300 East 66th StreetFloors 1 - 4New York, NY 10065
Overview of Dr. Seidman
Dr. Andrew Seidman is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital. He received his medical degree from Drexel University College of Medicine and has been in practice 37 years. Dr. Seidman accepts several types of health insurance, listed below. He is one of 514 doctors at Memorial Sloan Kettering Cancer Center and one of 384 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Internal Medicine, 1985 - 1988
Drexel University College of MedicineClass of 1985
Certifications & Licensure
NJ State Medical License 2020 - 2027
NY State Medical License 1989 - 2026
FL State Medical License 2019 - 2021
PA State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic Start of enrollment: 1998 Jul 01
- Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer Start of enrollment: 1998 Apr 01
- Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 Start of enrollment: 2000 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical Trial.Jonathan T Yang, Divya Yerramilli, Elena Pentsova, Suzanne Wolden, Robert J Young
JAMA Oncology. 2025-09-04 - 1 citationsClinicopathological features of microinvasive lobular carcinoma.Rachel Han, Atif A Hashmi, Hannah Y Wen, Melissa Murray, M Gabriela Kuba
Histopathology. 2025-08-01 - 1 citationsTreatment patterns and clinical outcomes of patients with HER2-positive T1micN0 breast cancer: a single-center analysis.Celine Yeh, Rachel Han, Abha Kulkarni, Charlie White, Yuan Chen
NPJ Breast Cancer. 2025-05-24
Authored Content
- A Phase IIA Trial of Acupuncture to Reduce Chemotherapy-Induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer PatientsAugust 2018
Press Mentions
Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer, Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS)December 11th, 2020- Odonate Therapeutics Announces Positive Top-Line Results from CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast CancerAugust 24th, 2020
Selected Abstracts from the San Antonio Breast Cancer SymposiumFebruary 11th, 2019- Join now to see all
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPOHumana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PHCS PPO - Kaiser
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
WEA Trust Preferred Provider Plan - Trust Pref - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
